TCMBANKIN036957 |
Citrusinine I |
|
|
301.29 g/mol |
|
TCMBANKIN037159 |
8-geranyl-7-hydroxycoumarin |
|
C19H22O3 |
298.4 g/mol |
CC(=CCCC(=CCC1=C(C=CC2=C1OC(=O)C=C2)O)C)C |
TCMBANKIN038399 |
α-Santalene |
ZINC64634147; alpha-santalene ; ZINC100506743; (+)-alpha-santalene; alpha-santalene; (1S,2R,4S,6R,7R)-1,7-dimethyl-7-(4-methylpent-3-en-1-yl)tricyclo[2.2.1.0(2,6)]heptane; KWFJIXPIFLVMPM-PEGGXJLSSA-N; CHEBI:61677; (2R,6S,7R)-1,7-DIMETHYL-7-(4-METHYLPENT-3-EN-1-YL)TRICYCLO[2.2.1.0(2),?]HEPTANE |
|
204.35 |
|
TCMBANKIN038416 |
Buxifoliadine A |
|
|
407.5 g/mol |
|
TCMBANKIN039889 |
1,2,3-Trihydroxyacridone |
|
|
243.21 g/mol |
|
TCMBANKIN040170 |
7-isovaleroylcycloseverinolide |
|
C31H38O9 |
554.6 g/mol |
CC(C)CC(=O)OC1C(C23C(=O)C=CC2(COC3(C)C)C4C1(C56C(O5)C(=O)OC(C6(CC4)C)C7=COC=C7)C)O |
TCMBANKIN040238 |
atalafoline |
|
C17H17NO6 |
331.32 g/mol |
CN1C2=CC(=C(C(=C2C(=O)C3=C1C(=C(C=C3)OC)OC)O)OC)O |
TCMBANKIN041221 |
7-Isovaleroylcycloepiatalantin |
|
|
552.6 g/mol |
|
TCMBANKIN041436 |
atalaphyllinine |
|
C23H23NO4 |
377.4 g/mol |
CC(=CCC1=C2C(=C3C(=C1O)C(=O)C4=C(N3)C(=CC=C4)O)C=CC(O2)(C)C)C |
TCMBANKIN042315 |
buxifoliadine h |
|
C16H15NO6 |
317.29 g/mol |
CN1C2=C(C=CC(=C2OC)O)C(=O)C3=C1C(=C(C=C3O)O)OC |
TCMBANKIN043901 |
atalaphyllidine |
|
C18H15NO4 |
309.3 g/mol |
CC1(C=CC2=C(O1)C=C(C3=C2NC4=C(C3=O)C=CC=C4O)O)C |
TCMBANKIN044022 |
citrusinine ii |
|
C15H13NO5 |
287.27 g/mol |
CN1C2=C(C=CC=C2O)C(=O)C3=C1C(=C(C=C3O)O)OC |
TCMBANKIN045799 |
glycocitrine i |
|
C20H21NO4 |
339.4 g/mol |
CC(=CCC1=C(C=C(C2=C1N(C3=C(C2=O)C=CC=C3O)C)O)OC)C |
TCMBANKIN045970 |
Buxifoliadine C |
|
|
325.4 g/mol |
|
TCMBANKIN046222 |
atalantolide |
|
C27H32O8 |
484.5 g/mol |
CC(=C1C(=O)C(C2(C(C1(C)C=CC(=O)OC)CCC3(C24C(O4)C(=O)OC3C5=COC=C5)C)C)O)C |
TCMBANKIN047188 |
n-methylatalaphylline |
|
C24H27NO4 |
393.5 g/mol |
CC(=CCC1=C2C(=C(C(=C1O)CC=C(C)C)O)C(=O)C3=C(N2C)C(=CC=C3)O)C |
TCMBANKIN047337 |
Buxifoliadine D |
|
|
361.4 g/mol |
|
TCMBANKIN048660 |
Buxifoliadine G |
|
|
363.4 g/mol |
|
TCMBANKIN048703 |
buxifoliadine f |
|
C16H11NO4 |
281.26 g/mol |
COC1=C2C(=C3C=COC3=C1)NC4=C(C2=O)C=CC=C4O |
TCMBANKIN048987 |
buxifoliadine e |
|
C23H25NO5 |
395.4 g/mol |
CC(=CCC1=C2C(=C(C3=C1NC4=C(C3=O)C=CC=C4O)O)CC(O2)C(C)(C)O)C |
TCMBANKIN049662 |
buxifoliadine b |
|
C24H27NO4 |
393.5 g/mol |
CC(C)C=CC1=C(C(=C2C(=C1O)C(=O)C3=C(N2)C(=CC=C3)O)CC=C(C)C)OC |
TCMBANKIN050154 |
severifoline |
|
C23H23NO3 |
361.4 g/mol |
CC(=CCC1=C2C(=C3C(=C1O)C(=O)C4=CC=CC=C4N3)C=CC(O2)(C)C)C |
TCMBANKIN058847 |
Auraptene |
7-[(2E)-3,7-dimethylocta-2,6-dienoxy]-2-chromenone; NCGC00096070-03; NCGC00096070-04; NSC711511; 7-[(2E)-3,7-dimethylocta-2,6-dienoxy]coumarin; auraptene; MLS001049098; SPECTRUM1505176; STOCK1N-26363; SMR000386931; 7-Geranyloxycoumarin; 7-[(2E)-3,7-dimethylocta-2,6-dienoxy]chromen-2-one; ACon1_000071; ZINC01658901; MEGxp0_000091; auraptene ; 7-(3,7-dimethylocta-2,6-dienoxy)-2-chromenone; 2H-1-Benzopyran-2-one, 7-((3,7-dimethyl-2,6-octadienyl)oxy)-, (E)-; UPCMLD-DP061:001; 7-(3,7-dimethylocta-2,6-dienoxy)chromen-2-one; 7-(3,7-dimethylocta-2,6-dienoxy)coumarin; Coumarin, 7-[(3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-; 2H-1-Benzopyran-2-one, 7-[(3,7-dimethyl-2,6-octadienyl)oxy]-, (E)-; 495-02-3; NCGC00096070-01; aurapten |
C19H22O3 |
298.4 g/mol |
CC(=CCCC(=CCOC1=CC2=C(C=C1)C=CC(=O)O2)C)C |
TCMBANKIN060679 |
stigmasterol |
|
C29H48O |
412.7 g/mol |
CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
TCMBANKIN061578 |
methyl trans-ferulate |
methyl ferulate;ferulic acid methyl ester;FERULIC ACID METHYL ESTER |
C11H12O4 |
208.21 g/mol |
COC1=C(C=CC(=C1)C=CC(=O)OC)O |